Overview

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults

Status:
COMPLETED
Trial end date:
2025-04-18
Target enrollment:
Participant gender:
Summary
To evaluate the safety and pharmacokinetic characteristics of AJU-C711 in healthy adults
Phase:
PHASE1
Details
Lead Sponsor:
AJU Pharm Co., Ltd.
Treatments:
Drug Evaluation